ATAGI update following weekly Covid meeting 12 May

Department of Health

ATAGI

Latest recommendation updates

ATAGI have not published any updated advice or recommendations since 29 April 2022.

Recent ATAGI considerations

On Wednesday 11 May 2022, ATAGI met to consider the latest developments relating to COVID-19 immunisation. As of 10 May 2022, over 58 million doses of COVID-19 vaccines have been administered in Australia.

ATAGI considered data on Omicron vaccine effectiveness in New South Wales and continued to examine evidence relating to need for 4th (winter) doses of COVID-19 vaccine for at risk groups, including individuals with disability and individuals with medical comorbidities.

Ongoing review of adverse events and safety information

The TGA Weekly Report provides a detailed breakdown of adverse events following immunisation, including Australian rates of myocarditis and pericarditis.

Resources and recent statements

/Media Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.